KESAR KESISHDA INTRAOPERATSION ANTIBIOTIK VA AUTOPLAZMOTERAPIYANING YIRINGLI-SEPTIK ASORATLARNI OLDINI OLISHDAGI SAMARADORLIGI
- Авторы:Asrankulova Diloramxon Baxtiyarovna, Nishonova Dilorom Axmatjanovna
- Дата публикации:July 17, 2026
- Тип:Статья
- DOI: 10.64156/mju.9543 Скопировано
- Том / № Выпуска:Том 1 №4 (2026)
Аннотация
Annotatsiya. Mazkur tadqiqot kesar kesishdan keyingi yiringli-septik asoratlarning oldini olishda intraoperatsion antibiotik va trombotsitlarga boy autoplazma (PRP) qo‘llash samaradorligini baholashga qaratilgan. Operativ tug‘ruqlardan keyin infeksion asoratlar ona salomatligiga salbiy ta’sir ko‘rsatishi sababli ularning profilaktikasi dolzarb muammo hisoblanadi. Kompleks yondashuv sifatida intraoperatsion antibiotikoterapiya va PRPning qo‘llanilishi infeksiyani nazorat qilish hamda reparativ jarayonlarni faollashtirish imkonini beradi. Tadqiqot natijalarida asosiy guruhda yiringli-septik asoratlar chastotasi sezilarli darajada kamaygani, shuningdek klinik tiklanish jarayoni tezlashgani aniqlandi.
Materiallar va usullar. Tadqiqotda 110 nafar ayol ishtirok etdi. Bemorlar ikki guruhga ajratildi: asosiy guruh (n=65) — intraoperatsion antibiotik va PRP qo‘llanildi; nazorat guruhi (n=45) — standart antibiotikoprofilaktika. Klinik, laborator va statistik tahlil usullari qo‘llanildi, ishonchlilik darajasi p<0,05 deb baholandi.
Xulosa. Intraoperatsion antibiotik va PRP kombinatsiyasi sinergik ta’sir ko‘rsatib, yiringli-septik asoratlarni kamaytiradi, yallig‘lanish jarayonlarini tezroq bartaraf etadi va gospitalizatsiya muddatini qisqartiradi. Ushbu yondashuv klinik amaliyotda samarali profilaktik usul sifatida tavsiya etilishi mumkin.
Kalit so‘zlar: kesar kesish, yiringli-septik asoratlar, PRP, antibiotikoprofilaktika, autoplazmaterapiya, klinik samaradorlik
Аннотация. Данное исследование направлено на оценку эффективности применения интраоперационных антибиотиков и аутоплазмы, обогащённой тромбоцитами (PRP), в профилактике гнойно-септических осложнений после кесарева сечения. Актуальность обусловлена высокой частотой инфекционных осложнений после оперативного родоразрешения. Комбинированный подход позволяет одновременно контролировать инфекционный процесс и активировать репаративные механизмы. Полученные результаты показали значительное снижение частоты осложнений и ускорение клинического восстановления у пациенток основной группы.
Материалы и методы. В исследование включены 110 женщин, разделённых на две группы: основная (n=65) — применялись интраоперационные антибиотики и PRP; контрольная (n=45) — стандартная антибиотикопрофилактика. Использованы клинические, лабораторные и статистические методы анализа (p<0,05).
Заключение. Комбинированное применение интраоперационных антибиотиков и PRP оказывает синергический эффект, снижает частоту гнойно-септических осложнений, ускоряет регресс воспаления и сокращает сроки госпитализации. Метод может быть рекомендован для широкого внедрения в клиническую практику.
Ключевые слова: кесарево сечение, гнойно-септические осложнения, PRP, антибиотикопрофилактика, аутоплазмотерапия, клиническая эффективность
Abstract. This study evaluates the effectiveness of intraoperative antibiotic administration combined with platelet-rich plasma (PRP) in preventing purulent-septic complications after cesarean section. The relevance of the study is обусловлена высокой частотой инфекционных осложнений после оперативных родов. The combined approach enables simultaneous infection control and activation of tissue repair processes. The results demonstrated a significant reduction in complication rates and faster clinical recovery in the main group.
Materials and Methods. A total of 110 women were included and divided into two groups: the main group (n=65) received intraoperative antibiotics and PRP, while the control group (n=45) received standard antibiotic prophylaxis. Clinical, laboratory, and statistical methods were applied, with significance set at p<0.05.
Conclusion. The combination of intraoperative antibiotics and PRP shows a synergistic effect, reducing purulent-septic complications, accelerating inflammatory resolution, and shortening hospital stay. This approach can be recommended for wider clinical implementation.
Keywords: cesarean section, purulent-septic complications, PRP, antibiotic prophylaxis, autologous plasma therapy, clinical effectiveness
References
- 1. Abubakar A., et al. Surgical site infections after cesarean section: global burden and prevention strategies. International Journal of Gynecology & Obstetrics. 2022;158(2):215–222.
- 2. ACOG (American College of Obstetricians and Gynecologists). Practice Bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. 2021.
- 3. Anderson D.J., et al. Strategies to prevent surgical site infections in acute care hospitals. Infection Control & Hospital Epidemiology. 2023;44(5):695–720.
- 4. Aziz N., et al. Role of platelet-rich plasma in wound healing and tissue regeneration. Journal of Clinical Medicine. 2023;12(4):1456.
- 5. Benedetti Panici P., et al. Antibiotic prophylaxis in cesarean delivery: current evidence. European Journal of Obstetrics & Gynecology. 2021;259:84–90.
- 6. Chaudhary R., et al. Platelet-rich plasma applications in obstetrics and gynecology. Reproductive Sciences. 2022;29(6):1743–1752.
- 7. D’Souza R., et al. Cesarean section surgical site infections: epidemiology and prevention. The Lancet Global Health. 2022;10(3):e355–e364.
- 8. Gyamfi-Bannerman C., et al. Prevention of infection after cesarean delivery. Obstetrics & Gynecology. 2023;141(2):345–356.
- 9. Hussain S., et al. Efficacy of platelet-rich plasma in surgical wound healing: systematic review. Annals of Medicine and Surgery. 2024;85:104–112.
- 10. Johnson A., et al. Local antibiotic administration in surgery: benefits and risks. Journal of Surgical Research. 2022;276:45–53.
- 11. Kawakita T., Landy H. Surgical site infections after cesarean delivery: current concepts. Seminars in Perinatology. 2021;45(2):151–159.
- 12. Kim J.H., et al. Advances in regenerative medicine: PRP and clinical applications. Stem Cells International. 2023;2023:1–10.
- 13. Liu Y., et al. Platelet-rich plasma in obstetrics: mechanisms and clinical outcomes. Frontiers in Medicine. 2024;11:1289456.
- 14. Mohamed M.A., et al. Antibiotic prophylaxis in cesarean section: updated perspectives. BMC Pregnancy and Childbirth. 2022;22:789.
- 15. Smaill F.M., Grivell R.M. Antibiotic prophylaxis versus no prophylaxis for cesarean section. Cochrane Database of Systematic Reviews. 2022;Issue 6.
- 16. Shahid M., et al. Platelet-rich plasma therapy in surgical wounds: clinical effectiveness. Wound Repair and Regeneration. 2023;31(2):210–218.
- 17. Tita A.T.N., et al. Adjunctive azithromycin prophylaxis for cesarean delivery. New England Journal of Medicine. 2021;384:1231–1241.
- 18. WHO (World Health Organization). Global guidelines for the prevention of surgical site infection. Updated 2025.
- 19. World Health Organization. WHO recommendations on cesarean section rates and outcomes. 2023.
- Zhang Q., et al. Clinical application of PRP in gynecology and obstetrics. Journal of Reproductive Medicine. 2024;69(1):25–33.